Site auhors
Marisa Alonso NĂșñez
Marisa Alonso NĂșñez is pharmacist and biochemist and has a PhD in molecular microbiology and genetics. She has been working as a research scientist at the Paterson Institute for Cancer Research in Manchester (UK) the past few years and she is currently working in the bi-centenarian Pharmacy NĂșñez in Astorga (Spain)
Instituto Carlos I
iC1 cultivates scientific research, both fundamental and applied, with a strong emphasis on the fields of theoretical physics and computational physics. Due to its university character, it also carries out teaching tasks by developing research focused on basic and interdisciplinary aspects of Theoretical Physics, studying the nature that surrounds us through mathematical and computational tools.
Ricardo Molero-Simarro
Ricardo Molero-Simarro is professor at the IAEU and a researcher at the Department of Applied Economics I of the University Complutense of Madrid (UCM). He is about to complete his PhD on China's economy. He has authored or co-authored several papers in peer-reviewed journals and co-edited a number of books, most of them related to economic development and income inequality issues.
Jon Gurutz Izquierdo
Jon graduated in Humanities and Communication (HUCO) at Deusto University in San SebastiĂĄn, and now is completing a Social Anthropology degree at the University of the Basque Country (UPV/EHU).
Paola Vega
Paola Vega studied Physics at the University of Oviedo (Spain) with 1-year specialization in Atomic and Molecular Physics. Afterwards she began her work on plasma based techniques for spectroscopic characterization of solid materials, which nowadays conforms her PhD thesis.
Pablo Barrecheguren
Pablo Barrecheguren obtained his Ph.D. in biomedicine from IRB (U. Barcelona) in 2014. He is involved in science communication since then.
Eduardo Oliver
Eduardo Oliver graduated in Pharmacy and got a PhD in Pharmacology at the University of Valencia. Currently he is a research associate at the Centre for Pharmacology and Therapeutics of Imperial College London (UK). His major interest is to better understand cardiovascular diseases and the use of genetics for finding new therapeutic targets.